phosphoramide has been researched along with 1,2-dioleoyloxy-3-(trimethylammonium)propane in 1 studies
Studies (phosphoramide) | Trials (phosphoramide) | Recent Studies (post-2010) (phosphoramide) | Studies (1,2-dioleoyloxy-3-(trimethylammonium)propane) | Trials (1,2-dioleoyloxy-3-(trimethylammonium)propane) | Recent Studies (post-2010) (1,2-dioleoyloxy-3-(trimethylammonium)propane) |
---|---|---|---|---|---|
77 | 0 | 21 | 703 | 2 | 279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clément, JC; Delépine, P; Férec, C; Fichou, Y; Hardy, E; Le Bris, M; Le Ny, K; Montier, T; Picquet, E; Yaouanc, JJ | 1 |
1 other study(ies) available for phosphoramide and 1,2-dioleoyloxy-3-(trimethylammonium)propane
Article | Year |
---|---|
KLN-5: a safe monocationic lipophosphoramide to transfect efficiently haematopoietic cell lines and human CD34+ cells.
Topics: Amides; Antigens, CD34; beta-Galactosidase; Blood Cells; Cell Line, Tumor; Cholesterol; Fatty Acids, Monounsaturated; Hematopoietic Stem Cells; Humans; Lipids; Organophosphorus Compounds; Phosphatidylethanolamines; Phosphoramides; Phosphoric Acids; Plasmids; Quaternary Ammonium Compounds; Structure-Activity Relationship; Transfection | 2004 |